Use of Pfizer Inc.'s COVID-19 antiviral Paxlovid spiked this week, but some doctors are reconsidering the pills for lower-risk patients after a U.S. public...
Research suggests that giving a person a vaccine through their nose can provide a better defense against future exposure to the coronavirus compared to...
Scientists have developed a machine learning model, called PyR0. The model analyzed millions of SARS-CoV-2 genomes and can predict which viral variants...
While the attention of public health authorities has been rivetted on the current COVID-19 pandemic, caused by the novel coronavirus SARS-CoV-2, many other...
A machine learning tool that can predict dominant SARS-CoV-2 variants could serve as an early warning system to help public health officials prepare for...
When a virus makes its way into a person’s body, one of the immune system’s first responders is a set of pathogen-removal cells called macrophages....
New experiments conducted in mice add to mounting evidence in opposition to a popular claim that COVID-19 vaccination during early pregnancy may cause...
Scientists are working on intranasal COVID vaccines. Not only are these vaccines delivered differently – but they also target a different part of our...
In unvaccinated people, infection with the Omicron variant of SARS-CoV-2 provides little long-term immunity against other variants according to a new study....
Moderna has joined forces with non-profit organisation IAVI on a third phase 1 trial of its candidate HIV The post Moderna’s HIV vaccine prepped for...
Session: D17, Top Knowledge in COVID Date and Time: 9:25 a.m. PT, Wednesday, May 18,2022 Location: Room 2018/2020 (West Building, Level 2), Moscone...
Like storm waves battering a ship, new versions of the SARS-CoV-2 virus have buffeted the world one after another. Recently, scientists keeping tabs on...
In a peer-reviewed study published May 17 in PLOS Medicine, scientists found that mRNA-based COVID-19 vaccines were superior to adenovirus vector-based...
SAN FRANCISCO, CA—May 18, 2022—In unvaccinated people, infection with the Omicron variant of SARS-CoV-2 provides little long-term immunity against...
Brand new UK startup RQ Biotechnology has been thrust into the spotlight after signing a $157 million licensing The post AstraZeneca buys into startup...
Enzolytics Inc (OTCMKTS: ENZC) is making a powerful move up the charts in recent days since reversing off $0.06 support levels, the second time it has...
A comparison of four COVID-19 vaccinations shows that messenger RNA (mRNA) vaccines — Pfizer-BioNTech and Moderna — perform better against the World...
AstraZeneca moved to bolster its COVID-19 portfolio of antibodies on Tuesday with a $157 million licensing deal for experimental therapies developed by...
LA JOLLA, CA—Last year, scientists at Scripps Research and Toscana Life Sciences studied the blood of 14 COVID-19 survivors to find the most potent antibodies...
MS patients treated with Rituximab have better responses to the COVID-19 vaccine if they have higher B cell counts. This is the finding of a study...
Funding: Medical Research Future Fund, mRNA Victoria, Jack Ma Foundation, IFM Investors, Australian Research Council and National Health and Medical Research...
BioNTech continues to build on the success of the company's mRNA COVID-19 vaccine co-developed with Pfizer, rapidly expanding its investigational pipeline...
Uncharacterised and so far rare cases of unexplained severe liver inflammation among young children. These cases of unexplained hepatitis have been appearing...
Your blood can hold a record of past illnesses. That information can reveal how many people have had a certain infection – like 58% of Americans...
Globally, breakthrough COVID-19 infections among vaccinated people are increasing, raising concerns about the durability of protection against emerging,...
LA JOLLA, CA—Getting sick with a common cold doesn’t make you immune to COVID-19, but a COVID-19 infection might, at least temporarily, boost the number...
Despite the loss of the company's COVID-19 antibody REGEN-COV earlier in 2022, Regeneron posted a positive first quarter driven primarily by sales of...
The mystery of exactly how the SARS-CoV-2 virus infects human lung cells remains largely hidden to experimental scientists. Now, however, the devilish...
Last week I invited 4 deeply experienced biopharma execs to gather for an hour to discuss what they’ve learned over the years about developing drugs....
Two new sublineages of the Omicron coronavirus variant can dodge antibodies from earlier infection well enough to trigger a new wave, but are far less...